Dahyana is a Manager of Program Management at Strand Therapeutics. She is a molecular biologist interested in the development of new mRNA therapeutics. Prior to joining Strand, Dahyana received her Ph.D. in Molecular Biophysics and Biochemistry from Yale University. Her research interests at Yale included developing new tools and techniques to understand biological systems, specifically those involved in RNA processing. Dahyana’s PhD research focused on comprehensively characterizing the Cajal Body, a nuclear body essential for proper RNA processing in cells. She received her B.S. in Biochemistry from Mount St. Mary’s University.
Daniel Hartman is an Engineer II, Data Analytics and Machine Learning at Strand Therapeutics. He completed his Bachelors in Biochemistry at Northeastern University. Prior to joining Strand Therapeutics, Dan worked in the Zupanc Neurobiology Laboratory at Northeastern, where he studied endogenous oscillators and the ionic mechanisms that drive their oscillation. He is proficient in exploring high-dimensional biological data sets and brings knowledge of high-performance computing to his role at Strand where he supports data-driven biological modeling using statistics and machine learning. Dan works primarily to design, build, and validate software tools for analyzing and optimizing mRNA therapeutics.
Daniel Loftus is a Scientist in the mRNA Programming team at Strand Therapeutics. He currently applies NGS methods to support Strand’s platform development. Prior to joining Strand, he was an NGS Scientist at Intellia Therapeutics, focusing on genotoxicity analysis of gene editing products for regulatory filings. He earned his Ph.D. at Harvard University as a member of Amanda Whipple’s lab, where he studied the effects of allele-specific chromatin structure on imprinted gene expression, and his B.S. at the University of Texas at Austin as a member of Arlen Johnson’s lab, where he studied eukaryotic ribosome biogenesis.
Danish is a Senior Associate Scientist in the Vector Engineering team at Strand Therapeutics. Prior to joining Strand, Danish completed his bachelor’s in biology from Calvin University and a master’s in biotechnology from the University of Texas at Tyler Health Science Center where his research focused on generating chimeric viruses containing highly conserved SARS-CoV-2 broadly neutralizing epitopes as vaccine candidates. In his free time, Danish likes playing/watching soccer, watching movies, and exploring.
Danny Gately is a Senior Scientist in Strand’s mRNA Process Development team. He is currently working to build Strand’s mRNA analytical and process development platforms and supporting process automation efforts. Danny is experienced in working with mRNA therapeutics. Before joining Strand in December 2020, he worked in mRNA analytical development at bluebird bio, where he helped to build the mRNA process and analytical platforms to a point of clinical readiness. Danny is a graduate of the University of Massachusetts Amherst, where he received his B.S. degree in Microbiology.
Elena Jacob is a Senior Associate in the People Sciences Department for Strand Therapeutics and is dedicated to facilitating a transparent and collaborative work environment. She holds a B.A. in Sociology and worked in the nonprofit world during her undergrad. Elena has built her career in Human Resources within a variety of industries, including sporting goods, banking, and food & beverage. She made her transition into the biotech space during Covid-19 where the importance of mRNA therapy became evident to everyone. In her role, she is responsible for supporting all things Human Resources, or as we like to call it, People Sciences. Outside of work, Elena enjoys going for walks, dancing, traveling, and trying new foods.
Eloise Wheeler is a Principal Associate Scientist on Strand’s Cellular Analytical Development team. She brings broad molecular and cellular biology experience spanning over 10 years in both academia and industry. Prior to Strand, she developed immunoassays at Ring Therapeutics as part of the technical operations team. Eloise graduated from Harvard University with a B.A. in Chemical and Physical Biology.
Emily Clinton is an Associate Scientist, In Vivo Discovery, at Strand. She has previously worked at the Ragon Institute of MGH, MIT and Harvard as a research veterinary technician in the Humanized Immune System Mouse Program researching an optimal mouse model to be applied to viral disease research. Emily received her B.S in Biology at the University of North Carolina Wilmington.
Emily is a Bioinformatics Scientist on the Data Analytics and Machine Learning team. She has extensive experience analyzing biological data and developing NGS pipelines for both immuno-oncology and neuroscience programs. Prior to joining Strand, she worked at Genocea Biosciences identifying and prioritizing neoantigens for personalized treatments, at Brigham and Women’s Hospital investigating auto-immune disease pathways using Next-Gen Sequencing, and at Harvard Medical School supporting structural biology applications. She received her M.S. in Bioinformatics from Northeastern University, and her B.S. in Neuroscience from University of California, Santa Cruz.
Errol Brown is a Manager of Lab Operations working in the Lab and Facilities Operations group with approximately 5 years of experience. He previously worked as a DENS contracted technician where he was responsible for tasks ranging from biowaste management to scheduling Pm’s for various instruments. He has a degree in graphic design and is always eager to flex his artistic muscle when possible. In his personal time, he enjoys playing darts, watching movies, listening to music, and staying current in the latest technology.
Eva is an Associate I of People and Office Administration for Strand Therapeutics and is committed to maintaining an accessible, inclusive, and well-organized office. She holds a B.A. in Geography and interned for a city government during her undergraduate career. In her role, she not only manages the office space, but is also responsible for many aspects of talent acquisition, and generally supports the People Sciences team.
